Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges

Frontiers in Psychiatry

Psychiatry

Nathan B. Sackett¹  Brian S. Barnett²  Anahita Bassir Nia³  Jeremy Weleff³ 

[1] Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States;Center for Novel Therapeutics in Addiction Psychiatry, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States;Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, United States;Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, United States;Department of Psychiatry, Yale University School of Medicine, New Haven, CT, United States;

关键词: psychedelics;    ketamine;    psilocybin;    addiction;    substance use disorder;   

DOI  :  10.3389/fpsyt.2023.1305478

 received in 2023-10-01, accepted in 2023-10-09,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Barnett, Bassir Nia, Sackett and Weleff.